BhagirathKMPaulsonKAhmadieRBhallaRSRobinsonDJassalDSClinical utility of cardiac magnetic resonance imaging in Churg–Strauss syndrome: case report and review of the literatureRheumatol Int200929445–44910.1007/s00296-008-0700-y
2.
BlanchardCRothenbergMEBiology of the eosinophilAdv Immunol200910181–12110.1016/S0065-2776(08)01003-1
3.
Cartin-CebaRKeoghKASpecksUSethiSFervenzaFCRituximab for the treatment of Churg–Strauss syndrome with renal involvementNephrol Dial Transplant2011262865–287110.1093/ndt/gfq852
4.
ChurgJStraussLAllergic granulomatosis, allergic angiitis, and periarteritis nodosaAm J Pathol195127277–301
5.
CoolsJDeAngeloDJGotlibJA tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndromeN Engl J Med20033481201–121410.1056/NEJMoa025217
6.
DonvikKKOmdalRChurg–Strauss syndrome successfully treated with rituximabRheumatol Int20093189–9110.1007/s00296-009-1146-6
7.
GotlibJEosinophilic myeloid disorders: new classification and novel therapeutic strategiesCurr Opin Hematol201017117–12410.1097/MOH.0b013e3283366c70
8.
GreenanTJGrossmanRIGoldbergHICerebral vasculitis: MR imaging and angiographic correlationRadiology199218265–72
9.
GuillevinLCohenPMahrATreatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patientsArthritis Rheum20034993–10010.1002/art.10922
10.
GuillevinLLhoteFGayraudMPrognostic factors in polyarteritis nodosa and Churg–Strauss syndrome. A prospective study in 342 patientsMedicine (Baltimore)19967517–2810.1097/00005792-199601000-00003
11.
HeisermanJEDrayerBPKellerPJFramEKIntracranial vascular stenosis and occlusion: evaluation with three-dimensional time-of-flight MR 12. angiographyRadiology1992185667–673
12.
HoganSPRosenbergHFMoqbelREosinophils: biological properties and role in health and diseaseClin Exp Allergy200838709–75010.1111/j.1365-2222.2008.02958.x
13.
JennetteJCFalkRJAndrassyKNomenclature of systemic vasculitides. Proposal of an international consensus conferenceArthritis Rheum199437187–19210.1002/art.1780370206
14.
KahnJEGrandpeix-GuyodoCMarrounISustained response to mepolizumab in refractory Churg–Strauss syndromeJ Allergy Clin Immunol2010125267–27010.1016/j.jaci.2009.10.014
15.
KimSMarigowdaGOrenEIsraelEWechslerMEMepolizumab as a steroid-sparing treatment option in patients with Churg–Strauss syndromeJ Allergy Clin Immunol20101251336–134310.1016/j.jaci.2010.03.028
16.
LanhamJGElkonKBPuseyCDHughesGRSystemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg–Strauss syndromeMedicine (Baltimore)19846365–81
17.
MasiATHunderGGLieJTThe American College of Rheumatology 1990 criteria for the classification of Churg–Strauss syndrome (allergic granulomatosis and angiitis)Arthritis Rheum1990331094–110010.1002/art.1780330806
18.
MetzgerothGWalzCErbenPSafety and efficacy of imatinib in chronic eosinophilic leukaemia and hypereosinophilic syndrome: a phase-II studyBr J Haematol2008143707–71510.1111/j.1365-2141.2008.07294.x
19.
NairPPizzichiniMMKjarsgaardMMepolizumab for prednisone-dependent asthma with sputum eosinophiliaN Engl J Med2009360985–99310.1056/NEJMoa0805435
RibiCCohenPPagnouxCTreatment of Churg–Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patientsArthritis Rheum200858586–59410.1002/art.23198
22.
RothenbergMEKlionADRoufosseFETreatment of patients with the hypereosinophilic syndrome with mepolizumabN Engl J Med20083581215–122810.1056/NEJMoa070812
23.
Sable-FourtassouRCohenPMahrAAntineutrophil cytoplasmic antibodies and the Churg–Strauss syndromeAnn Intern Med2005143632–638
24.
SaechJOwczarczykKRosgenSPetereitHHallekMRubbert-RothASuccessful use of rituximab in a patient with Churg–Strauss syndrome and refractory central nervous system involvementAnn Rheum Dis2010691254–125510.1136/ard.2009.109850
25.
SehgalMSwansonJWDeRemeeRAColbyTVNeurologic manifestations of Churg–Strauss syndromeMayo Clin Proc199570337–34110.4065/70.4.337
26.
SinicoRADi TomaLMaggioreUPrevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg–Strauss syndromeArthritis Rheum2005522926–293510.1002/art.21250
27.
StockKWRadueEWJacobALBaoXSSteinbrichWIntracranial arteries: prospective blinded comparative study of MR angiography and DSA in 50 patientsRadiology1995195451–456
28.
WadleighMTefferiAClassification and diagnosis of myeloproliferative neoplasms according to the 2008 World Health Organization criteriaInt J Hematol201091174–17910.1007/s12185-010-0529-5
29.
ZwerinaJAxmannRJatzwaukMSahinbegovicEPolzerKSchettGPathogenesis of Churg–Strauss syndrome: recent insightsAutoimmunity200942376–37910.1080/08916930902832348
